Daizo Yoshida

1.6k total citations
74 papers, 1.3k citations indexed

About

Daizo Yoshida is a scholar working on Cancer Research, Oncology and Molecular Biology. According to data from OpenAlex, Daizo Yoshida has authored 74 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 29 papers in Cancer Research, 28 papers in Oncology and 25 papers in Molecular Biology. Recurrent topics in Daizo Yoshida's work include Protease and Inhibitor Mechanisms (16 papers), Cell Adhesion Molecules Research (13 papers) and Cancer, Hypoxia, and Metabolism (11 papers). Daizo Yoshida is often cited by papers focused on Protease and Inhibitor Mechanisms (16 papers), Cell Adhesion Molecules Research (13 papers) and Cancer, Hypoxia, and Metabolism (11 papers). Daizo Yoshida collaborates with scholars based in Japan, United States and China. Daizo Yoshida's co-authors include Akira Teramoto, Shozo Nakazawa, Yukio Ikeda, Maode Wang, Tuo Wang, Kunihiro Watanabe, Kyongsong Kim, Yuichi Sugisaki, Akira Teramoto and Atsushi Teramoto and has published in prestigious journals such as British Journal of Cancer, Annals of Oncology and Neurosurgery.

In The Last Decade

Daizo Yoshida

74 papers receiving 1.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Daizo Yoshida Japan 19 481 391 380 203 169 74 1.3k
Chang Hun Rhee South Korea 22 968 2.0× 287 0.7× 405 1.1× 268 1.3× 194 1.1× 34 1.8k
Deborah M. Heuvelman United States 15 1.1k 2.4× 272 0.7× 417 1.1× 92 0.5× 268 1.6× 15 1.8k
Wenqing Yao United States 17 557 1.2× 437 1.1× 253 0.7× 75 0.4× 159 0.9× 67 1.5k
Randall Schreck United States 9 1.5k 3.1× 686 1.8× 469 1.2× 131 0.6× 117 0.7× 13 2.3k
Gabriele D. Maurer Germany 17 671 1.4× 214 0.5× 385 1.0× 289 1.4× 46 0.3× 36 1.2k
R. Christopher Harmon United States 11 434 0.9× 358 0.9× 136 0.4× 211 1.0× 68 0.4× 13 1.1k
Anica Dricu Romania 26 811 1.7× 374 1.0× 423 1.1× 317 1.6× 121 0.7× 78 1.6k
Marie‐Paule Lachambre Canada 12 386 0.8× 333 0.9× 356 0.9× 68 0.3× 130 0.8× 13 983
Samuel Seoane Spain 18 492 1.0× 361 0.9× 183 0.5× 157 0.8× 73 0.4× 38 1.1k
Monica Gatti Italy 20 561 1.2× 467 1.2× 217 0.6× 194 1.0× 84 0.5× 26 1.1k

Countries citing papers authored by Daizo Yoshida

Since Specialization
Citations

This map shows the geographic impact of Daizo Yoshida's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Daizo Yoshida with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Daizo Yoshida more than expected).

Fields of papers citing papers by Daizo Yoshida

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Daizo Yoshida. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Daizo Yoshida. The network helps show where Daizo Yoshida may publish in the future.

Co-authorship network of co-authors of Daizo Yoshida

This figure shows the co-authorship network connecting the top 25 collaborators of Daizo Yoshida. A scholar is included among the top collaborators of Daizo Yoshida based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Daizo Yoshida. Daizo Yoshida is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Kono, Kenichi, Kosaku Mimura, Y. Yoshimoto, et al.. (2021). 1393P Phase I/II clinical trial of combination of anti-PD-1 mAb, nivolumab with radiotherapy for unresectable and recurrent gastric cancer who failed to standard chemotherapy. Annals of Oncology. 32. S1053–S1054. 1 indexed citations
2.
Terao, Takeshi, Masahiro Mishina, Ichiro Takumi, et al.. (2011). Early computed tomography signs as early predictors of hemorrhagic transformation under heparinization in patients with cardiogenic embolism. Geriatrics and gerontology international. 12(3). 418–424. 1 indexed citations
3.
Bao, Yijun, Daizo Yoshida, Daijiro Morimoto, & Akira Teramoto. (2006). Expression of Laminin β2: A Novel Marker of Hypoxia in Pituitary Adenomas. Endocrine Pathology. 17(3). 251–262. 4 indexed citations
4.
Morimoto, Daijiro, et al.. (2006). Phosphorylation of cAMP response element binding protein (CREB) as a marker of hypoxia in pituitary adenoma. Journal of Neuro-Oncology. 79(2). 143–150. 4 indexed citations
5.
Wang, Maode, et al.. (2005). Expression of Cathepsin B and microvascular density increases with higher grade of astrocytomas. Journal of Neuro-Oncology. 71(1). 3–7. 16 indexed citations
6.
Wang, Maode, et al.. (2005). Inhibition of cell invasion by indomethacin on glioma cell lines: in vitro study. Journal of Neuro-Oncology. 72(1). 1–9. 23 indexed citations
10.
Yoshida, Daizo, Kunihiro Watanabe, Hiroshi Takahashi, Yuichi Sugisaki, & Akira Teramoto. (2003). Apoptotic induction by BE16627B on human malignant glioma cell lines by an anti-matrix metalloproteinase agent. Brain Tumor Pathology. 20(1). 13–19. 1 indexed citations
11.
Wang, Maode, et al.. (2003). The expression of matrix metalloproteinase-2 and-9 in human gliomas of different pathological grades. Brain Tumor Pathology. 20(2). 65–72. 163 indexed citations
13.
Watanabe, Kunihiro, et al.. (2001). Suppression of Matrix Metalloproteinase-2 and -9 Mediated Invasivenessbreak by a Novel Matrix Metalloproteinase Inhibitor, BE16627B. Journal of Neuro-Oncology. 52(1). 1–9. 17 indexed citations
14.
Yoshida, Daizo, et al.. (2001). Induction of apoptosis by estramustine phosphate mediated by phosphorylation of bcl-2. Journal of Neuro-Oncology. 54(1). 23–29. 2 indexed citations
15.
Yoshida, Daizo, Yuichi Sugisaki, Tomonori Tamaki, et al.. (2000). Intracranial Malignant Meningioma with Abdominal Metastases Associated with Hypoglycemic Shock: A Case Report. Journal of Neuro-Oncology. 47(1). 51–58. 12 indexed citations
16.
Bergenheim, A. Tommy, Roger Henriksson, J Piepmeier, & Daizo Yoshida. (1996). Estramustine in malignant glioma. Journal of Neuro-Oncology. 30(1). 81–9. 10 indexed citations
17.
Yoshida, Daizo, Ann Cornell-Bell, & Joseph M. Piepmeier. (1994). Selective Antimitotic Effects of Estramustine Correlate with Its Antimicrotubule Properties on Glioblastoma and Astrocytes. Neurosurgery. 34(5). 863–868. 16 indexed citations
18.
Piepmeier, Joseph M., David L. Keefe, Marc A. Weinstein, et al.. (1993). Estramustine and Estrone Analogs Rapidly and Reversibly Inhibit Deoxyribonucleic Acid Synthesis and Alter Morphology in Cultured Human Glioblastoma Cells. Neurosurgery. 32(3). 422–431. 26 indexed citations
19.
Yoshida, Daizo, Yukio Ikeda, Hiroshi Takahashi, Toshiro Shimura, & Shozo Nakazawa. (1993). Intracranial fibromyxoma in a four-year-old child. Surgical Neurology. 39(3). 191–195. 2 indexed citations
20.
Yoshida, Daizo, Yukio Ikeda, & Shozo Nakazawa. (1993). Quantitative analysis of copper, zinc and copper/zinc ratio in selected human brain tumors. Journal of Neuro-Oncology. 16(2). 109–115. 164 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026